Minneapolis, MN, United States of America

Kathleen Lauser

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 25.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Kathleen Lauser

Introduction

Kathleen Lauser, an accomplished inventor based in Minneapolis, MN, has made significant contributions to the field of pharmaceutical sciences. With one patent to her name, she exemplifies the spirit of innovation in the industry, particularly through her work at Bristol-Myers Squibb Company.

Latest Patents

Lauser's notable patent is titled "Process for the preparation of N-((1R,2S,5R)-5-(-butylamino)-2-((S)-3-(7--butylpyrazolo[1,5-a][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide." This invention relates to an improved method for the synthesis of a specific compound that showcases her expertise in organic chemistry and drug development.

Career Highlights

Throughout her career, Kathleen has been associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company known for its commitment to research and development. Her work focuses on advancing innovative therapeutic solutions, contributing to the improvement of patient outcomes across various medical fields.

Collaborations

Lauser collaborates with talented coworkers such as Burcu Selin Aytar and Alina Borovika, who share her passion for innovation in the pharmaceutical sector. Together, they contribute to creating groundbreaking solutions that push the boundaries of conventional drug development techniques.

Conclusion

Kathleen Lauser's achievements highlight the vital role that innovative minds play in advancing healthcare. Her patented work not only demonstrates her dedication to scientific progress but also signifies the collaborative efforts within her company to develop medications that can make a real difference in patients' lives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…